禹洲(01628.HK)急吐12%失20天線成交創逾兩年高 中績少賺近38%
禹洲集團(01628.HK)中績少賺近38%,該股扭四連漲,股價由七個月高位回落失守20天及10天線(3.72元及3.85元),最低見3.58元,全日收3.65元,回吐12%,成交急增至4,278萬股,創逾兩年高,涉資1.57億元。
禹洲昨天收市後公布,中期純利按年減近38%至10.19億元人民幣(下同),每股盈利18.43分,但中期股息按年維持12港仙,但去年同期另派3港仙特別股息。期內,總營收按年升20.4%至140.07億元;不包括投資物業公允值收益、扣除遞延稅項之溢利按年升近5%至15.44億元。累積合約銷售金額按年升50.5%至428.5億元,完成全年目標42.85%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.